Business Context and Reporting Period
Company: TriSalus Life Sciences, Inc. (TLSI)
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2026
Reporting Period: Second quarter ended June 30, 2026
Event: Announcement of financial results for the second quarter of 2026 via press release (Exhibit 99.1).
Key Financial Metrics
The provided Form 8-K text serves as a notification of the results announcement and incorporates the press release by reference. It does not contain specific numerical data.
- Revenue: Not provided in the filing text.
- Profit/Loss: Not provided in the filing text.
- Cash Flow: Not provided in the filing text.
- Margins: Not provided in the filing text.
- Debt and Liquidity: Not provided in the filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These disclosures are contained within the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2026) for actual financial figures.
- Verify the specific revenue and net income/loss for the quarter ended June 30, 2026.
- Check for any updated full-year guidance or operational milestones mentioned in the press release.
- Confirm the status of the company's warrants (TLSIW) and any potential dilution impacts if discussed in the full release.